S.

Neurocrine Biosciences , Inc. The presentation will be webcast and can be accessed on
the Company's website at http://www .
Viewers are encouraged to visit the website approximately 5 minutes prior to
the presentation to download or install any necessary software. news releases are available through the Company's
website via the Internet at http://www.

Many organizations are formed for the purpose of raising money for research , treatment, or the support of patient and families.

disorders neurological

SAN DIEGO, Neurocrine Biosciences, Inc. Adams ' direction, Kos has
become fully profitable through internal strategic growth as well as through
product acquisitions and in-licensing arrangements.

treatment patient

Adams spent over 30 years in senior management positions with major
pharmaceutical companies, including Novartis Pharmaceuticals, SmithKline
Beecham and ICI Pharmaceuticals (Astra Zeneca).org.

pancreas sclerosis

com

raising formed

Our product
candidates address some of the largest pharmaceutical markets in the world
including insomnia, anxiety, depression, diabetes , multiple sclerosis,
irritable bowel syndrome, eating disorders, pain, and autoimmunity. These tools
guide the institutional development process and offer support to attain
positive health outcomes among a variety of health services providers.

SALUD LATINA/LATINO HEALTH

Chicago office
53 W.

treatment aids

"

Kos, one of the fastest growing pharmaceutical companies in the U. Under Mr.
If you are unable to attend the webcast and would like further information
on this announcement please contact the Investor Relations Department at
Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Jones or
Elizabeth Foster.S.

patient conditions

Adams is President and CEO
of Kos Pharmaceuticals , Inc. (Nasdaq: KOSP).

deficiency disorders

demyelinating endocrine

Live Webcast on Tuesday, May 3, 2005

SAN DIEGO , Neurocrine Biosciences,
Inc.

raising diseases

Lyons, President and Chief Executive Officer of Neurocrine
Biosciences .neurocrine.

cancer purpose

The live presentation will take place at 8:30am Eastern Daylight Time
(EDT) / 5:30am Pacific Daylight Time (PDT) and will include indiplon marketing
highlights and an update on the Company's broad development pipeline and
research programs. CHICAGO, Reducing health disparities , especially
those impacting Latinos living in the U.

cystic purpose

neurocrine.

cystic demyelinating

conditions fibrosis

Neurocrine Biosciences to Present at the 30th Annual Deutsche Bank Healthcare Conference

In response to this challenge, capacity-building organizations
are in charge of developing tools to help health organizations'
infrastructure, information gathering and data interpretation.

diabetes disorders

com

formed multiple

(Nasdaq: NBIX) announced today that the Company has appointed Adrian Adams to
its Board of Directors effective immediately. is a product -based biopharmaceutical company
focused on neurological and endocrine diseases and disorders.

Neurocrine Biosciences, Inc. Under its new
name, SALUD LATINA/LATINO HEALTH will provide capacity -building and
programmatic development on a variety of diseases and chronic conditions
affecting Latinos, such as HIV/AIDS, tobacco dependency, obesity, diabetes,
cancer and child abuse.ereleases .

cystic fibrosis

Neurocrine Biosciences Announces the Appointment of Adrian Adams to the Board of Directors

, (Nasdaq: NBIX) a biopharmaceutical company focused on neurological and
endocrine diseases and disorders announced today that Gary Lyons, President
and CEO will present at the 30th Annual Deutsche Bank Healthcare Conference at
the Hyatt Regency Hotel in Baltimore, Maryland, on Tuesday, May 3, 2005.

purpose multiple

,
reported sales of $90 million in 2001 and is expected to report sales of
approximately $735 million in 2005.
Neurocrine Biosciences, Inc.com., is a key priority in the nation's
health agenda. For more information,
visit http://www.

immune pancreas

news releases are available through the Company 's
website via the Internet at http://www.

Highly Recognized Latino Capacity-Building Organization Changes Its Name

SALUD LATINA/LATINO HEALTH, formerly known as the Midwest Hispanic Health
Coalition, a pioneer in the field of HIV and a highly recognized capacity-
building organization in the Midwest, announces a new name.

disorders demyelinating

cystic patient

Prior to joining Kos,
Mr.neurocrine. SALUD LATINA/LATINO HEALTH provides services
and training in: management skills, financial management, technical skill
development , community participatory research, non-profit communication and
social marketing strategies.
Suite K
Aurora, IL 60505
Phone: (630) 892-6371
Contact: Daniel Villarreal

This release was issued through eReleases(TM).

money disorders

A replay of the webcast will be available approximately one hour after the
presentation concludes and will be archived until Tuesday, May 17 , 2005. The organization's purpose is to ensure appropriate
treatment and early intervention helping service providers such as health
departments, academic institutions, planning groups and community -based
organizations to strengthen their ability to provide culturally-sound and
high-quality services to Latinos.salud-latina.com.

immune money

Mr. Jackson Blvd.
Suite 1322
Chicago, IL 60604
Phone: (312) 913-3001
Contact: Mayra Chacon

Aurora office
143 South Lincoln Ave.

cancer treatment

Our product
candidates address some of the largest pharmaceutical markets in the world
including insomnia, anxiety, depression, diabetes, multiple sclerosis,
irritable bowel syndrome, eating disorders , pain, and autoimmunity.
Neurocrine Biosciences, Inc. For additional information, please visit our
website, http://www.

immune genetic

"Adrian's extensive experience in launching major pharmaceutical global
brands and developing products in many therapeutic areas will be of great
benefit to Neurocrine as we embark on our commercialization program," said
Gary A. "His strategic vision and proven track record in managing
pharmaceutical development as well as sales and earnings growth will be a
valuable resource for Neurocrine. is a product-based biopharmaceutical company
focused on neurological and endocrine diseases and disorders.